Genome Profiling LLC (GenPro) is a bioinformatics company specializing in the discovery of novel epigenetic biomarkers based on its proprietary, genome-wide methylation profiling platform to revolutionize the way we treat, diagnose, and predict chronic and life-threatening diseases.
Genome Profiling – epigenetic biomarkers
Genome Profiling applies its scientific expertise in a revolutionary computational genetic-analysis technology to transform standard next-generation DNA sequencing data into actionable information that enables researchers and clinicians to make precision medicine a reality for patients afflicted with life-threatening diseases.
Genome Profiling LLC provides quantitative biomarker analysis of DNA methylation profiles for personalized health diagnostics, disease prediction, and therapeutic monitoring. Central to its approach is a proprietary analytical and profiling software platform that transforms routine DNA genome sequence data into deep insights into the dynamic epigenome of individual patients. Therefore, Genome Profiling LLC is able to identify new and important biomarkers for specific disease states. Its epigenetic analysis results provide researchers with actionable information that supports faster, more confident decision making and enables better outcomes for patient health.
GenPro Analytics, its proprietary, specialized software platform, employs genome-wide methylation profiling algorithms to discover novel epigenetic biomarkers. Capitalizing on the exponential growth in next-generation sequencing (NGS) and the rising interest in and demand for epigenetic-profiling technologies and analysis of NGS data, GenPro Analytics drives transformational improvements across the entire NGS value chain while seamlessly integrating with current NGS pipelines and workflows. From reducing the cost, time, and complexity of preparing genomic DNA for sequencing to delivering highly sensitive and accurate quantitative whole-genome methylation profiles and novel epigenetic biomarkers, Genome Profiling LLC’s cloud based analytical services enable biopharma and research institutions to achieve game-changing improvements in personalized disease prediction, diagnosis, and treatment.
Genome Profiling LLC is based on Newark (USA). Management Team is composed by Jeb Connor, Adam Marsh, Didier Landais, Mort Goldman, Annamarie Pasqualone and Andrew Taylor. Advisory Board is composed by Irene Rombel, James Serum, Tracy Shickel and Ian Wright.
More about Genome Profiling : www.genprollc.com